Search results
TAMASYA: Group Exhibition Dari Wild Skids di SOL Gallery
HYPEBEAST· 6 days agoBerlangsung sampe tanggal 23 Juni 2024 nanti.
Gateway - The Root
The Root· 6 days agoBlock Club Chicago recently broke open a story that brings to bear many of the seediest issues perpetuating inequity in the notoriously segregated city and the country it belongs to: greed, ...
Cozad juniors slow comeback secures win over Gothenburg Melons
Lexington Clipper-Herald· 7 days agoThe Gothenburg junior Melons hosted the Cozad Reds juniors for a night on the diamond on Friday,...
GoLocalProv | Business | What You Can Buy in Rhode Island’s East Bay Between $4M and $7M
GoLocalProv· 2 days agoThe folks at Mott & Chace Sotheby's International are presenting three East Bay estates. Escape to...
Apple now offers AI training for thousands of students and alumni
ZDNet· 6 days agoThe rise of artificial intelligence has made it even more critical for employees to upskill, with a...
Chairman of Italy’s state-controlled shipbuilder dies | FOX 28 Spokane
FOX 28 Spokane· 7 days agoThe chairman of Italy’s state-controlled shipbuilder Fincantieri, Claudio Graziano, a retired...
Avinger Announces Closing of up to $24 Million Public Offering
Digital Journal· 7 days agoH.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The aggregate gross proceeds to the Company from the offering were approximately $6 million before deducting the ...
Search for dozens feared missing after deadly migrant shipwrecks off Italy | Fox 11 Tri Cities Fox...
FOX 11/41 Yakima· 7 days agoThe Italian coastguard searched off southern Italy Monday for survivors or the bodies of dozens of...
Gateway - Jalopnik
Jalopnik· 5 days agoA Chicagoland Mitsubishi dealership has a wild idea for you: Ride around in a $3,799,999 Learjet turned into a limo. Yes, this creation is being sold for $3,799,999 at a dealership where you ...
Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel...
Morningstar· 4 days agoALPHA3 Trial Has the Potential to Position Cema-cel as Part of First Line (1L) Treatment for LBCL to Improve Cure RatesFirst Prospective Trial to Incorporate the Foresight Diagnostics’s Investigational CLARITY™ Test to Identify Patients with LBCL Who